117 related articles for article (PubMed ID: 17645247)
1. Asymptomatic persistence of anti-Yo antibodies for 5 years without relapse of malignancy.
Finsterer J; Unterberger U; Grisold W
Neuropathology; 2007 Jun; 27(3):300-4. PubMed ID: 17645247
[TBL] [Abstract][Full Text] [Related]
2. Atypical paraneoplastic syndrome associated with anti-Yo antibodies.
Finsterer J; Bodenteich A; Drlicek M
Clin Neuropathol; 2003; 22(3):137-40. PubMed ID: 12809356
[TBL] [Abstract][Full Text] [Related]
3. Antibody-positive paraneoplastic neurologic syndromes: value of CT and PET for tumor diagnosis.
Linke R; Schroeder M; Helmberger T; Voltz R
Neurology; 2004 Jul; 63(2):282-6. PubMed ID: 15277621
[TBL] [Abstract][Full Text] [Related]
4. Small cell lung cancer associated with anti-Hu paraneoplastic sensory neuropathy and peripheral nerve microvasculitis: case report and literature review.
Ansari J; Nagabhushan N; Syed R; Bomanji J; Bacon CM; Lee SM
Clin Oncol (R Coll Radiol); 2004 Feb; 16(1):71-6. PubMed ID: 14768759
[TBL] [Abstract][Full Text] [Related]
5. Antibodies of the anti-Yo and anti-Ri type in the absence of paraneoplastic neurological syndromes: a long-term survey of ovarian cancer patients.
Drlicek M; Bianchi G; Bogliun G; Casati B; Grisold W; Kolig C; Liszka-Setinek U; Marzorati L; Wondrusch E; Cavaletti G
J Neurol; 1997 Feb; 244(2):85-9. PubMed ID: 9120501
[TBL] [Abstract][Full Text] [Related]
6. Intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with antineuronal autoantibodies.
Uchuya M; Graus F; Vega F; Reñé R; Delattre JY
J Neurol Neurosurg Psychiatry; 1996 Apr; 60(4):388-92. PubMed ID: 8774401
[TBL] [Abstract][Full Text] [Related]
7. Accuracy of FDG-PET/CT and paraneoplastic antibodies in diagnosing cancer in paraneoplastic neurological syndromes.
Vatankulu B; Yilmaz Aksoy S; Asa S; Sager S; Sayman HB; Halac M; Sonmezoglu K
Rev Esp Med Nucl Imagen Mol; 2016; 35(1):17-21. PubMed ID: 26260889
[TBL] [Abstract][Full Text] [Related]
8. Deterioration of anti-Yo-associated paraneoplastic cerebellar degeneration.
Finsterer J; Voigtländer T; Grisold W
J Neurol Sci; 2011 Sep; 308(1-2):139-41. PubMed ID: 21762925
[TBL] [Abstract][Full Text] [Related]
9. Paraneoplastic neurological syndromes in patients with carcinoid.
Tschernatsch M; Dierkes C; Gerriets T; Hosch J; Stolz E; Kaps M; Krasenbrink I; Claus D; Blaes F
Eur J Neurol; 2008 Dec; 15(12):1390-4. PubMed ID: 19049559
[TBL] [Abstract][Full Text] [Related]
10. Detection of autoantibodies to the BTB-kelch protein KLHL7 in cancer sera.
Bredholt G; Storstein A; Haugen M; Krossnes BK; Husebye E; Knappskog P; Vedeler CA
Scand J Immunol; 2006 Sep; 64(3):325-35. PubMed ID: 16918702
[TBL] [Abstract][Full Text] [Related]
11. Paraneoplastic neuropathy: wide-ranging clinicopathological manifestations.
Koike H; Tanaka F; Sobue G
Curr Opin Neurol; 2011 Oct; 24(5):504-10. PubMed ID: 21799410
[TBL] [Abstract][Full Text] [Related]
12. Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients.
Shams'ili S; Grefkens J; de Leeuw B; van den Bent M; Hooijkaas H; van der Holt B; Vecht C; Sillevis Smitt P
Brain; 2003 Jun; 126(Pt 6):1409-18. PubMed ID: 12764061
[TBL] [Abstract][Full Text] [Related]
13. Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration in a female patient with pleural malignant mesothelioma.
Tanriverdi O; Meydan N; Barutca S; Ozsan N; Gurel D; Veral A
Jpn J Clin Oncol; 2013 May; 43(5):563-8. PubMed ID: 23475537
[TBL] [Abstract][Full Text] [Related]
14. Paraneoplastic cerebellar syndromes associated with antibodies against Purkinje cells.
Schwenkenbecher P; Chacko L; Pul R; Sühs KW; Wegner F; Wurster U; Stangel M; Skripuletz T
Int J Neurosci; 2018 Aug; 128(8):721-728. PubMed ID: 29199513
[TBL] [Abstract][Full Text] [Related]
15. Anti-Yo positive dorsal root ganglionopathy.
McNamara P; Costelloe L; Langan Y; Redmond J
J Neurol; 2011 Mar; 258(3):519-20. PubMed ID: 20931213
[No Abstract] [Full Text] [Related]
16. Survival and outcome in 73 anti-Hu positive patients with paraneoplastic encephalomyelitis/sensory neuronopathy.
Sillevis Smitt P; Grefkens J; de Leeuw B; van den Bent M; van Putten W; Hooijkaas H; Vecht C
J Neurol; 2002 Jun; 249(6):745-53. PubMed ID: 12111309
[TBL] [Abstract][Full Text] [Related]
17. Lateral medullary syndrome with anti-neuronal antibodies (anti-Ta/Ma2) in primary Sjogren's syndrome.
Mehta P; Fernando MM; Pickering MC; Wilson Y; Molloy S; Colaco CB
Rheumatology (Oxford); 2009 Sep; 48(9):1174-6. PubMed ID: 19620208
[No Abstract] [Full Text] [Related]
18. [A study on pathomechanisms of paraneoplastic neurological syndrome].
Tanaka K
Rinsho Shinkeigaku; 2001 Dec; 41(12):1150-2. PubMed ID: 12235823
[TBL] [Abstract][Full Text] [Related]
19. Screening for anti-titin antibodies in patients with various paraneoplastic neurological syndromes.
Berger B; Stich O; Labeit S; Rauer S
J Neuroimmunol; 2016 Jun; 295-296():18-20. PubMed ID: 27235344
[TBL] [Abstract][Full Text] [Related]
20. [Diagnosis of paraneoplastic polyneuropathy in patients with breast cancer and small cell lung cancer].
Koroleva ES; Losenkov IS; Alifirova VM; Ivanova SA; Goldberg VE; Novikova NS
Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(4):93-6. PubMed ID: 24874327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
